Related Experiment Video
Updated: Aug 7, 2026

Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis
Published on: January 30, 2018
Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats
A Szabó1, M G Freesmeyer, K Abendroth
1C. Ruprecht University Heidelberg, Germany; I. Semmelweis University Budapest, Hungary.
Background:
Low bone turnover despite normal parathyroid hormone (PTH) concentrations has been found in many patients with end-stage renal failure. Hyporesponsiveness to the calcaemic action is also a known feature of uraemia. Hyporesponsiveness of bone surface cells involved in bone modelling has not been demonstrated to date. It was the purpose of this study using a rat model of moderate renal failure to investigate whether doses of PTH and calcitriol that reverse the effect of parathyroidectomy on calcaemia also normalize bone surface cell activity.
Materials And Methods:
Sham-operated pair-fed male Spraque-Dawley rats were compared with subtotally nephrectomized (SNX), parathyroidectomized (PTX) rats that received either solvent or calcitriol (5 pmol kg -1 h-1) + 1,34 rat PTH (100 ng kg -1 h-1) by osmotic mini-pump. Histomorphometric measurements were carried out in the vertebral body (L5).
Results:
In SNX/PTX animals, calcitriol + 1,34 rat PTH caused a modest increase in serum calcium (S-Ca) within the normal range. Osteoclast surface per cent was significantly lower in solvent-treated SNX/PTX rats than in sham-operated controls [3.7 +/- 2.8 osteoclast surface/bone surface (OcS/BS%) vs. 6.3 +/- 3.9], and this was not normalized by PTH + calcitriol (3.3 +/- 3). In contrast, osteoblast surface per cent and osteoid surface per cent were increased over values in sham-operated rats; as a result, co-administration of calcitriol and 1,34 rat PTH caused a highly significant increase in fractional bone volume (BV/TV).
Conclusions:
The results show that administration of PTH and calcitriol in doses that raise serum calcium fails to normalize the percentage of osteoclast surface, but was effective in raising osteoblast number and osteoblast volume in experimental renal failure. The results argue for abnormal response of bone cells to calcium-regulating hormones and/or the action of factors other than calcium regulatory hormones in the genesis of skeletal abnormalities of renal failure.
Insights
In experimental renal failure, parathyroid hormone (PTH) and calcitriol normalize osteoblast activity but not osteoclast surface. This suggests abnormal bone cell responses contribute to skeletal issues in kidney disease.
Area of Science:
- Nephrology
- Endocrinology
- Bone Biology
Background:
- Patients with end-stage renal failure often exhibit low bone turnover despite normal parathyroid hormone (PTH) levels.
- Uremia is known to cause hyporesponsiveness to the calcaemic action of hormones.
- Hyporesponsiveness of bone surface cells in bone modeling in uremia has not been previously demonstrated.
Purpose of the Study:
- To investigate if PTH and calcitriol can normalize bone surface cell activity in a rat model of moderate renal failure.
- To determine if hormonal doses that correct serum calcium levels also affect bone modeling in uremic rats.
Main Methods:
- Subtotally nephrectomized (SNX) and parathyroidectomized (PTX) rats were treated with either a solvent or a combination of calcitriol and rat PTH.
- Histomorphometric measurements of bone parameters were performed on vertebral bodies (L5).
- Serum calcium levels were monitored.
Main Results:
- Calcitriol and PTH administration modestly increased serum calcium in SNX/PTX rats, within the normal range.
- Osteoclast surface per cent was significantly lower in solvent-treated SNX/PTX rats and was not normalized by PTH and calcitriol.
- Osteoblast surface and osteoid surface per cent increased in treated rats, leading to a significant increase in bone volume.
Conclusions:
- PTH and calcitriol, at doses that increase serum calcium, failed to normalize osteoclast surface in experimental renal failure.
- These hormones were effective in increasing osteoblast number and volume.
- The findings suggest abnormal bone cell responses to hormones or other factors contribute to skeletal abnormalities in renal failure.
Related Concept Videos
Bone Remodeling
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...

